Brian Rini
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) (NCT07188896) | Brian Rini | 2026-04-29 |
Track Brian Rini automatically
Every clearance here is in the API, with alerts when new ones post.